Compare Moderna, Inc. (MRNA) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Snap On Incorporated — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Snap On Incorporated trades at $402.3 (market cap $21.06B). The key difference: Moderna, Inc. and Snap On Incorporated are close in size by market cap, and Snap On Incorporated pays a 2.4% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | SNA | |
|---|---|---|
Market Cap | $23.60B | $21.06B |
Sector | Health | Technology |
52-Week High | $81.80 | $414.97 |
52-Week Low | $22.36 | $317.79 |
Enterprise Value | $19.70B | $20.58B |
Dividend Yield | — | 2.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
